CompletedNot Applicable

A Single-center, Prospective, Clinical Study of VersaWrap Utilization in the Hand

United States17 participantsStarted 2022-09-01

Plain-language summary

The purpose of this study is to evaluate the efficacy on the use of VersaWrap® in surgery of the hand/fingers, including tendon repair, fracture repair, or tenolysis of the hand/fingers. VersaWrap is designed to allow tendon gliding and to protect tendon gliding postoperatively

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients aged 18-70 at the time of surgery
✓. Patients undergoing hand/finger surgery, including tendon repair, fracture repair or tenolysis
✓. Psychosocially, mentally and physically able to fully comply with this protocol including adhering to follow-up schedule, study requirements with a signed informed consent with a study collaborator present at the time of signing to ensure compliance.

Exclusion criteria

✕. Non-English speaking
✕. Known allergy or sensitivity to citrate, alginate or hyaluronate
✕. Pregnant or breastfeeding
✕. Currently a prisoner
✕. Patient has any condition, that in the opinion of the Investigator, would prohibit the patient from complying with the protocol

What they're measuring

Number of participants diagnosed with post-operative tenolysis

Timeframe: 6 months

Trial details

NCT IDNCT05598801

SponsorResearch Source

Sponsor typeNETWORK

Study typeOBSERVATIONAL

Primary completion2025-08-17

View on ClinicalTrials.gov More Tendon Repair trials